Oral nitrate therapy does not affect glucose metabolism in healthy men

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 11, 2009, Pages 1086-1092

  Henstridge, Darren C ^a,b   Duffy, Stephen J ^a   Formosa, Melissa F ^a   Ahimastos, Anna A ^a   Thompson, Bruce R ^c   Kingwell, Bronwyn A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Exhaled nitric oxide; Glucose; Metabolism; Nitrates; Nitric oxide; Type 2 diabetes

Indexed keywords

CYCLIC GMP; GLUCOSE; INSULIN; ISOSORBIDE 5 NITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PENTAERYTHRITYL TETRANITRATE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LUNG BLOOD FLOW; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; SUSTAINED DRUG RELEASE;

ADULT; BLOOD GLUCOSE; CYCLIC GMP; DELAYED-ACTION PREPARATIONS; GLUCOSE TOLERANCE TEST; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PENTAERYTHRITOL TETRANITRATE; PULMONARY CIRCULATION;

EID: 68149172939     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05195.x     Document Type: Article

References (31)

1. Bjornholm M, Zierath JR. Insulin signal transduction in human skeletal muscle: Identifying the defects in Type II diabetes. Biochem. Soc. Trans. 2005 33 : 354 357.
2. King PA, Betts JJ, Horton ED, Horton ES. Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle. Am. J. Physiol. 1993 265 : R447 52.
3. Dohm GL, Tapscott EB, Pories WJ et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 1988 82 : 486 494.
4. Giacca A, Groenewoud Y, Tsui E, McClean P, Zinman B. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with Type 2 diabetes and mild hyperglycemia. Diabetes 1998 47 : 1763 1770.
5. Kennedy JW, Hirshman MF, Gervino EV et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with Type 2 diabetes. Diabetes 1999 48 : 1192 1197.
6. Balon TW, Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J. Appl. Physiol. 1994 77 : 2519 2521.
7. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 1997 82 : 359 363.
8. Etgen Jr. GJ, Fryburg DA, Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 1997 46 : 1915 1919.
9. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001 50 : 241 247.
10. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A. Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action. Diabetes 1997 46 : 1691 1700. (Pubitemid 27456399)
11. Young ME, Radda GK, Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 1997 322 : 223 228.
12. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell GK. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with Type 2 diabetes more than in control subjects. Diabetes 2002 51 : 2572 2580.
13. Henstridge DC, Kingwell BA, Formosa MF, Drew BG, McConell GK, Duffy SJ. Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with Type 2 diabetes. Diabetologia 2005 48 : 2602 2608.
14. Dikalov S, Fink B, Skatchkov M, Stalleicken D, Bassenge E. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance. J. Pharmacol. Exp. Ther. 1998 286 : 938 944.
15. Kojda G, Hacker A, Noack E. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production. Eur. J. Pharmacol. 1998 355 : 23 31.
16. Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits. J. Cardiovasc. Pharmacol. 1995 25 : 763 773.
17. Fink B, Bassenge E. Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate. J. Cardiovasc. Pharmacol. 1997 30 : 831 836.
18. Duck KD, Richard F. [Long-term nitrate therapy in coronary heart disease: Loss of effect by developing tolerance.] Z. Gesamte Inn. Med. 1990 45 : 736 741 (in German).
19. Dikalov S, Fink B, Skatchkov M, Bassenge E. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: Effect of vitamin C. Free Radic. Biol. Med. 1999 27 : 170 176.
20. Dikalov S, Skatchkov M, Fink B, Bassenge E. Quantification of superoxide radicals and peroxynitrite in vascular cells using oxidation of sterically hindered hydroxylamines and electron spin resonance. Nitric Oxide 1997 1 : 423 431.
21. Vandivier RW, Eidsath A, Banks SM et al. Down-regulation of nitric oxide production by ibuprofen in human volunteers. J. Pharmacol. Exp. Ther. 1999 289 : 1398 1403.
22. Daiber A, Wenzel P, Oelze M, Munzel T. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin. Res. Cardiol. 2008 97 : 12 20.
23. MIMS Australia. MIMS online prescribing information: Imdur Durules-Isosorbide Mononitrate. 2009. Available from: http://www.mims.hcn.net. au/ifmx-nsapi/mims-data/?Mival=2MIMS-abbr-pi&product-code= 2445&product-name=Imdur+Durules (accessed January 2009).
24. Zenger MR, Brenner M, Haruno M, Mahon D, Wilson AF. Measurement of cardiac output by automated single-breath technique, and comparison with thermodilution and Fick methods in patients with cardiac disease. Am. J. Cardiol. 1998 71 : 105 109.
25. Bergandi L, Silvagno F, Russo I et al. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 2215 2221.
26. Jensen J, Sharikabad MN, Ostbye KM, Melien O, Brors O. Evidence that nitroprusside stimulates glucose uptake in isolated rat cardiomyocytes via mitogen-activated protein kinase. Arch. Physiol. Biochem. 2003 111 : 239 245.
27. Lander HM, Sehajpal P, Levine DM, Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 1993 150 : 1509 1516.
28. Tanaka T, Nakatani K, Morioka K et al. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes. Eur. J. Endocrinol. 2003 149 : 61 7.
29. Van Dyke DA, Walters L, Frieswyk D, Kokmeyer D, Louters LL. Acute effects of troglitazone and nitric oxide on glucose uptake in L929 fibroblast cells. Life Sci. 2003 72 : 2321 2327.
30. McGarry JD. Banting Lecture 2001. Dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes 2002 51 : 7 18.
31. Kleschyov AL, Oelze M, Daiber A et al. Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ. Res. 2003 93 : E104 12.